bimekizumab
Bimzelx, a potential blockbuster for psoriasis, clears FDA approval after resolving manufacturing issues
Anika Sharma
UCB’s long-awaited FDA approval for its psoriasis therapy, Bimzelx (bimekizumab), has finally arrived, ending a journey marked by manufacturing setbacks. ...
UCB’s psoriasis drug application overcomes manufacturing hurdle but hits another FDA delay
Anika Sharma
After facing delays related to manufacturing issues, UCB’s psoriasis medication, bimekizumab, is awaiting the next steps in its FDA review ...